IP Library Granted Patent US 8,524,658
Granted Patent B2
US 8,524,658 · App. 13/319,661 · Granted Sep 3, 2013

Lactoferrin and brain health and development in infants

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,524,658
App. No.
13/319,661
Granted
Sep 3, 2013
Kind
B2
Abstract

The present invention relates generally to the field of brain development and brain health. One embodiment of the present invention relates to a composition that can be used for the treatment or prevention of a delayed brain development and/or a delayed development of the nervous system. Also cognitive performance can be increased.

Claims (13)

1. A method for use in the treatment of a delayed brain development and/or a delayed development of the nervous system comprising administering a composition comprising lactoferrin in a concentration of 2 g-25 g/100 kcal of the composition to an individual in need of same.

2. A method for use in the repair of a delayed brain development and/or a delayed development of the nervous system comprising administering a composition comprising lactoferrin in a concentration of 2 g-25 g/100 kcal of the composition to an individual in need of same.

3. A method for use in the treatment of a delayed vision development, a delayed neural migration, and/or a delayed cognitive development comprising administering a composition comprising lactoferrin in a concentration of 2 g-25 g/100 kcal of the composition to an individual in need of same.

4. A method for use in the treatment of an impaired learning ability, an impaired mental performance, an impaired memory or a reduced attention span comprising administering a composition comprising lactoferrin in a concentration of 2 g-25 g/100 kcal of the composition to an individual in need of same.

5. A method in accordance with claim 1 , wherein the composition is to be administered to an individual selected from the group consisting of mothers during pregnancy, mothers during lactation, premature or term born babies, infants, toddlers, children and teenagers.

6. A method in accordance with claim 2 , wherein the composition is to be administered to an individual selected from the group consisting of mothers during pregnancy, mothers during lactation, premature or term born babies, infants, toddlers, children and teenagers.

7. A method in accordance with claim 3 , wherein the composition is to be administered to an individual selected from the group consisting of mothers during pregnancy, mothers during lactation, premature or term born babies, infants, toddlers, children and teenagers.

8. A method in accordance with claim 4 , wherein the composition is to be administered to an individual selected from the group consisting of mothers during pregnancy, mothers during lactation, premature or term born babies, infants, toddlers, children and teenagers.

9. Method of claim 1 , wherein the composition is administered to provide at least 0.2 g lactoferrin per kg of body weight of the individual per day.

10. Method of claim 1 , wherein the composition is administered to provide at least 1 g lactoferrin per kg of body weight of the individual per day.

11. Method of claim 1 , wherein the individual to whom the composition is administered has a delayed brain development and/or a delayed development of the nervous system.

12. Method of claim 3 , wherein the individual to whom the composition is administered has a delayed vision development, a delayed neural migration, and/or a delayed cognitive development.

13. Method of claim 3 , wherein the individual to whom the composition is administered has an impaired learning ability, an impaired mental performance, an impaired memory or a reduced attention span.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →